GINSENG KIANPI PIL — Class II drug recall D-0329-2015
Terminated recall by One and Zen, reported 2015-01-07, distributed nationwide. Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and
| Recall number | D-0329-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | One and Zen, Albuquerque, NM, United States |
| Recall initiated | 2014-11-20 |
| Classified | 2014-12-30 |
| Reported by FDA | 2015-01-07 |
| Terminated | 2015-03-23 |
| Distributed | Nationwide (US) |
| Quantity | 38 bottles |
| Reason classes | undeclared allergen, unapproved product |
Product
GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0329-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.